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Abstract 
Tumour-activated prodrug (TAP) is designed to aim at increasing the 
prodrug selectivity to kill cancer cells.  One strategy to  is to design a TAP 
containing an amine cytotoxin, present as an amide function, which could 
be released more rapidly in the low pH environment of tumour tissues 
when amide undergoes hydrolysis.   
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The prodrug model (1) was the subject of the current study.  At lower pH 
its un-ionised carboxylic acid group provides neighbouring catalysis of 
hydrolysis of the adjacent amide.  It was synthesised via ring-opening of 
the imide (2) which itself was directly synthesised from endo-
bicyclo[2.2.2]octa-5-ene-2,3-dicarboxylic anhydride and p-methoxyaniline.    
 
The pH-rate profile of (1) was established over the pH range of 3-10, 
covering rapid hydrolysis of un-ionised acid-amide at lower pH but slower 
imide formation above pH 8 from the ionised acid-amide. From the kinetic 
data were calculated the dissociation constant for (1) (pKa: 5.1 at 30°C) 
and limiting lower pH rate constant for hydrolysis of (1) in its fully neutral 
form (klim: 0.44 min
-1 at 30°C).  The data in the pH range of 8-10 provided 
klow (0.067 min
-1) representing formation of (2) from fully ionised (1). 
 
The following equilibrium reaction was also investigated at high pH, at 
which (1) was in its fully ionised amide carboxylate form, by kinetic studies 
on (2) in hydroxide solutions. 
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Imide + OH-  Amide carboxylate 
 
The second order rate constant for the forward reaction, kf, was 74 L mol
-1 
min-1 which with klow for the reverse reaction gave K as 1100 L mol
-1.   
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1 Introduction 
1.1 Cancer 
1.1.1 What is cancer? 
A cancer is a growth or lump that damages surrounding tissues and 
organs, and that may spread to other parts of the body1.  It is not a single 
disease but a large group of disorders with different symptoms.  Most 
cancers form tumour but some, like leukaemia, do not.  However, 
nowadays, there is a grey zone between the terms cancer and tumour, 
which are being used interchangeably. 
   
Today, cancer is a leading cause of death worldwide.  This disease is 
accounted for 7.5 million deaths (around 13% of all deaths worldwide) in 
2005 and it is predicted that 84 million people will die in the next 10 years 
if no further action is taken2.  Lung, stomach, colorectal, liver and breast 
cancer cause the most cancer deaths each year.   
 
Cancer normally arises from one single cell transforming into a tumour cell.  
This is a result of the interaction between a person’s genetic factors and 
other external agents, i.e. carcinogens.  Carcinogens can bring damage to 
some specific genes known as oncogenes that regulate important cell 
process like cell division, growth, repair, and self-destruction of faulty cells.  
Some examples of carcinogens include smoke, industrial wastes, food by-
products, and radiation. 
   
Normally most damaged genes are repaired by the cell metabolism 
system, but eventually they can be altered or mutated if they are regularly 
exposed to carcinogenic sources.  These damaged oncogenes can have 
altered versions of their chemicals within cells, and eventually the cell 
becomes cancerous (Figure 1-1). 
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a. Normal cell being exposed to carcinogenic sources 
b. Some of the genes are eventually damaged with continuing bombardment of 
carcinogens. 
c. Newly-damaged oncogenes are usually soon repaired, but with time or 
continuous and/or high exposure to carcinogens, some of the oncogenes suffer 
permanent damages. 
d. With a few oncogenes being permanently altered, key cell functions are 
irreparably affected, resulting in a cancerous cell being formed. 
Figure 1-1: Formation of cancerous cell by exposure to carcinogens 
 
Ageing is another fundamental factor for the development of cancer2.  The 
incidence of cancer rises dramatically with age, most likely due to a build-
up of risks for specific cancers that increases with age.  The overall risk 
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accumulation is combined with the tendency of cellular repair mechanisms 
to be less effective as a person grows older.   
 
All cancers begin with a single normal cell, converting from a normal state 
to an abnormal cancerous state.  During this process, the cells acquire 
three main malignant properties that distinguish them as cancer cells3: 
1. An uncontrolled growth/division beyond their usual boundaries 
2. A diminished ability to undergo apoptosis 
3. An ability to spread (from the site of origin) 
 
An uncontrolled growth/division 
As in every normal cell, cancer cells have the ability to divide among 
themselves to form large clusters of cells.  When a normal cell is 
transformed into a cancer cell, it multiplies until tumours are formed and 
can be ultimately detected.  It is generally thought that one billion cancer 
cells need to have formed before a cancer can be detected. 
 
The difference between a normal growth and a cancer growth is that 
normal growth happens in a controllable and precisely timed manner, 
whereas cancer cells divide freely without any restraints.  This property 
has been taken into account by many medical researchers in the 
development of cancer treatment methods.  Since the cancer cells are 
more actively dividing than the normal cells, they are therefore more 
readily being exposed to certain chemotherapies and radiation treatments. 
 
It has to be aware that although cancer cells are growing in an 
uncontrollable manner, this does not necessarily mean that cancer is 
always caused by cells “growing out of control” or “running amuck”.  There 
are some types of cancers, especially true in the case of solid tumours, do 
not grow like wildfire but at a very slow rate – in some cases slower than 
the normal cell divisions.  The dominant problem with this kind of tumour is 
mostly due to the cells’ “near-immortality”, which leads to the second 
malignant property of the cancer cells. 
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A diminished ability to undergo apoptosis 
Every cell has a finite, predetermined life span, either long or short.  To 
maintain the balance of numbers of cells in the body, a system – encoded 
in every single cell’s DNA (deoxyribonucleic acid) - exists to eliminate the 
diseased, defective and old cells, replacing them with the new ones.  This 
system operates through a process called apoptosis, which causes the 
cells’ internal parts to dissolve leading to cell suicide.  In Greek, apoptosis 
means falling off, as in leaves from a tree or petals from a flower.   
 
The concept of apoptosis is very important here because it is well known 
that cancer cells have a diminished ability to undergo apoptosis in which 
they are supposed to be eliminated naturally.  This occurs because they 
have an altered genetic programme of apoptosis brought by DNA 
mutations, i.e. change in nucleotide sequences of the genetic material.  
This results in the switching-off of apoptosis process in cancer cells, 
leading to infinite growth of tumour mass. 
 
An ability to spread from the site of origin 
Another important concept in oncology is metastasis.  This is the process 
in which the cancer cells spread from the site of origin, called the “primary” 
site, to other locations in the body, called “metastatic” or “secondary” sites.   
 
At the primary site the cells get loosen and eventually dissolve the forces 
that bind them to their neighbouring cells.  The freed cells can then enter 
the bloodstream or lymphatic channels and travel to the metastatic sites 
by forming new blood vessels – a process named “angiogenesis” – to gain 
access to the blood circulation.   
 
Normally each type of cancer has its associated “preferred” metastatic 
sites.  By gaining knowledge of these sites the initial assessment of the 
extent of disease can thence be carried out.   
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1.1.2 Types of Cancer 
There are hundreds of distinct types of cancer, while each is grouped into 
four main categories3: 
1. Carcinomas – Cancers derived from epithelial cells. 
2. Hematologic malignancies – These cancers are related to the blood 
and lymph systems in the body (hema is Greek for blood).  They 
cause alterations of blood counts, enlargement of lymph nodes, or 
defects in the body’s immune defences, resulting in infections.    
The most commonly known cancer from this type is leukaemia 
which does not form tumours.      
3. Sarcomas – Derived from the supporting structures, including 
muscle, bone, cartilage, fibrous tissue, fat, nerves, and blood and 
lymphatic vessels, of the body (sarc-oma is Greek for “fleshy 
growth”).   
4. Brain tumours – These occur in the central nervous system, 
protected by a barrier of bones and membranes and bathed in 
spinal fluid.  Unlike the other types of cancers, they do not spread 
to the rest of the body.   
 
1.1.3 Treatments targeting cancer cells 
Some of the conventional cancer therapies include3, 4: 
 Surgery 
 Radiotherapy – Using radiation to kill cancer cells and to shrink 
tumours by damaging the genetic material in the cells and stops 
them from multiplying. 
 Chemotherapy – Using drugs to interfere with the ability of cancer 
cells to proliferate. 
 Targeted therapy – Targeting the receptors, signalling molecules 
and/or angiogenesis process to disrupt cancer cell growth.   
 Hormonal therapy – Using drugs to block the production of 
hormones responsible for growth of cancer, e.g. oestrogen or 
testosterone the reproductive organs. 
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 Cryotherapy – Using extreme cold – e.g. nitrogen probes - to 
destroy cancer cells.   
 Brachytherapy – By implanting catheters, needles, capsules or 
seeds containing radioactive materials to kill cancer cells. 
 
1.2 Tumour-Activated Prodrug 
1.2.1 Disadvantages of most anticancer drugs today 
As mentioned above, chemotherapy uses drugs to stop cancer cells from 
proliferating.  It is well known today that a lot of these drugs can bring 
some side effects to at least some level to the cancer patients.  These side 
effects include hair loss, vomiting and nausea, to name a few.   
 
The majority of the clinically-used anticancer drugs today are systemic 
cytotoxins that kill the cancer cells primarily by attacking their DNA.  On 
one hand these drugs are efficient to kill large number of cancer cells with 
constant proportion kinetics – many exhibit a log-linear relationship 
between carcinoma cells and drug concentration5; on the other hand they 
are not truly selective to the cancer cells that their therapeutic efficacy is 
highly limited by the damage they cause to the normal cells which might 
be essential for life.  This can be a major concern especially in the case of 
treating solid tumours which are dividing relatively slow compared to the 
normal cells.   
 
As a result, not only the anticancer drugs have very limited benefits to 
treat the cancer, they are also bringing more of other damages to the body 
of the patients.  To solve this problem and increase the clinical efficacy of 
the anticancer drugs, one way is the use of relatively non-toxic prodrug 
forms that can be selectively activated in tumour tissue.   
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1.2.2 Prodrugs 
Prodrugs can be defined as agents that are transformed after 
administration, either by metabolism or spontaneous chemical breakdown, 
to form pharmacologically active species6.  About 5-7% of drugs approved 
worldwide today can be classified as prodrugs7.   
 
The efficacy of anticancer drug is generally directly dependent on the drug 
concentration as well as its time of exposure.  Deactivating the drug as a 
prodrug until needed at the site of action is extremely useful – and quite 
commonly used - to improve the solubility, transport and pharmacokinetic 
properties of the anticancer agents8. 
 
1.2.3 Tumour-activated prodrugs 
There is an increasing interest in developing tumour-activated prodrugs 
(TAPs) which are aimed at increasing the selectivity of the prodrugs to kill 
the cancer cells, leaving the rest of the normal cells unharmed.     
 
A TAP design must fulfil certain requirements.  First, they must be able to 
be delivered to the distant regions in tumours, and thereby be selectively 
activated to generate a cytotoxic species to kill the tumour tissues only.  
Second, they must be capable to produce a “bystander effect” - the ability 
to diffuse a limited distance to kill neighbouring tumour cells that may lack 
the ability to activate the prodrug6.  This is a crucial requirement because 
in many cases only a small proportion of tumour cells is likely to possess 
the ability to activate a prodrug.   
 
A modular approach to the design of TAP is to have a molecule consists of 
three domains: trigger, effector and linker units (Figure 1-2)6.  The linker, 
acting as an inter-bridge linking the trigger and effector units, deactivates 
the prodrug until the trigger unit undergoes a metabolism carried out by 
one of the tumour-specific mechanisms.  The linker then rapidly transmits 
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the change to the effector, which destroys tumour cells rapidly and under 
all conditions of pH and cell cycle status.    
 
 
Figure 1-2: General layout of a tumour-activated prodrug (TAP) design 
 
A TAP can be selectively activated via various mechanisms, mainly based 
on: 
i. Tumour physiology - e.g. selective enzyme expression, hypoxia and 
pH differences. 
ii. Drug delivery techniques - e.g. antibody-directed enzyme-prodrug 
therapy (ADEPT) and gene-directed enzyme-prodrug therapy 
(GDEPT). 
 
In this context we will be focusing on the activation of TAP by the pH-
differences between tumour and normal tissues. 
 
1.2.4 pH-sensitive TAPs 
There have been very few well-documented consistent differences 
between normal cells and tumour cells, one of them being the pH 
differences – tumour tissues are found to have lower extracellular pH (pHe) 
values than the normal tissues9.     
 
The expanding population of tumour cells often lead to insufficient 
nutritional supplies by the functional vasculature system, leading to 
deficiency of oxygen.  Hence under anaerobic conditions lactic acid is 
produced, together with the hydrolysis of adenosine-5’-triphosphate (ATP) 
in an energy-deficient environment, giving a relatively more acidic 
environment in tumour tissues.  It is therefore commonly believed that 
hypoxia and acidity co-exist in the microenvironment of tumour tissues. 
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Warburg10 found that tumour tissues depended greatly on glycolysis for a 
source of metabolic energy, and hence proposed in 1923 that these cells 
had impairment of respiration system.  As a rule, one mole of breathed 
oxygen causes the disappearance of 1-2 mole of lactic acid.  Warburg’s 
hypothesis was based on the fact that the respiration does not cause the 
glycolysis to disappear in tumour tissues. 
 
This hypothesis was later proved to be wrong, as tumour tissues were 
showed to be fully able to use respiration as a source of metabolic energy.  
Weinhouse11 claimed that the reason for the persistence of glycolysis in 
oxygen is that it is so high in tumours that a normal respiration and a 
normal Pasteur effect are incapable of eliminating it.  It is thus believed 
that the tumour cells use anaerobic glycolysis as primary source for 
obtaining metabolic energy due to the existence of hypoxic regions in 
which oxygen is not available for respiration process.   
 
Glycolysis is also referred as the Embden-Meyerhof pathway (refer to 
Appendix A for the complete pathway).  Under anaerobic conditions, 2 mol 
of lactic acid and 2 mol of ATP are produced for every mol of glucose 
consumed.  The production of protons via the ATP hydrolysis here is 
thought to be the major cause of acidity in tumours, although additional 
pathways may also lead to acid production.   
 
A poor chaotic tumour vascularisation often leads to an inefficient removal 
of the acidic products and contributes further to development of the 
chronically acid extracellular environment12.   
 
In a cell, there is a constant loading of acid, which is generated 
metabolically and through passive diffusion of H+ (equivalents), due to the 
internally negative membrane potential.  As pHi has to be maintained 
above the equilibrium pH13, it is closely regulated by recruiting some H+-
consuming mechanisms to transport these proton ions to the extracellular 
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space of the cell during aerobic/anaerobic glycolysis, glutaminolysis, and 
ATP hydrolysis processes.   
 
Some major transport mechanisms responsible for regulation of pHi in 
acid-loaded cells include the Na+/H+ antiport and the Na+-dependent 
HCO3
-/Cl- exchanger.  Other membrane transporters, such as H+-ATPase 
pumps, lactate:proton symport, and increased turnover of acidic vesicles, 
may also contribute to the regulation of pHi by extruding protons from 
cells9, 12-14.  Via the interstitial space these proton ions are removed from 
the tissues through the blood vessels by convective transport. 
 
Rapidly growing tumours usually have a high metabolic rate and a high 
lactic acid production (as discussed previously).  If these conditions 
coincide with an insufficient proton removal system, the proton ions 
accumulate in the tissues and give a lower pHe values.  Thus the active 
regulation of pHi has highlighted the problem of tumour pHe/pHi differential.   
 
Investigations carried out by Newell et al.15 indicate that solid tumours 
derived from glycolysis-deficient cells do not accumulate lactic acid above 
serum levels yet are as acidic as parental tumours.  They proposed that 
the acid production is due to the poor removal of CO2 produced by 
inadequate tumour vasculature, allowing sufficient time for the hydration of 
CO2 to carbonic acid H2CO3 and hence giving a net H
+ production within 
solid tumours.  Further experiments are however necessary to evaluate 
this finding. 
 
pHe is conventionally measured by insertion of pH electrodes, whereas 
intracellular pH (pHi) is more conveniently measured by 
31P-NMR 
spectroscopy techniques.  Wike-Hooley et al.16 had done a comprehensive 
review of several thousand microelectrode measurements of pH in human 
and animal tumours, which summarised that tumours are more acidic than 
normal tissues with median pH values of about 7.0 in tumours and 7.5 in 
normal tissues.  Investigations carried out by Vaupel et al.17 also showed 
that for C3H mouse mammary carcinomas, most of the measured pH 
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values are in the range of 6.4 to 7.1, with an absolute value as low as 5.8 
observed in large ulcerated tumours.        
 
Thus, cell-excluded prodrugs those are able to be selectively activated at 
the lower-than-normal pHe occurring in tumour tissues, releasing potent 
cytotoxins that can enter cells, have significant theoretical advantages as 
anticancer drugs.   
 
However, relatively little work has been reported on prodrugs of this type, 
mainly because the pH difference involved is not large, at maximum 
perhaps 1 unit (from the pH 7.4 in normal tissues down to about pH 6.5 in 
severely hypoxic regions of solid tumours9).  It is therefore necessary to 
find chemistries that are sensitive to small pH changes.   
 
One approach is to construct prodrugs containing amine cytotoxins 
present as amide functions but designed to be released when the amide 
undergoes hydrolysis, and hopefully getting a rate differential significantly 
in favour of pH 6 over pH 7.  Amides generally are non-reactive in 
hydrolysis at physiological pH but neighbouring un-ionised carboxylic acid 
groups provide dramatic catalysis by cyclisation to release amine (see 
section 1.3).  
 
Normal acids have pKa values of around 4-5 so the challenge is to find 
compounds containing acid groups which are still incompletely ionised at 
around pH 6.  A system with a higher absolute reaction rate because of 
structural or conformational constraints on orientation of the acid and 
amide groups is also required.   
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1.3 Amide Hydrolysis 
Under physiological conditions the hydrolysis of amides exhibits half-lives 
of about 7 years, as investigated by Kahne et al. using a radioassay 
experiment at neutral pH and room temperature18.  There are however a 
few papers that reported on enhanced hydrolysis rates for some amides, 
such as Bender’s phthalic acid amide (t1/2 of 49 minutes and 17.5 hours at 
pH 3.0 and 5.0, respectively, at 47.5°C; 105 faster than the corresponding 
benzamide)19, N-n-propyldiisopropylmaleamic acid (t1/2 less than 1 second 
at 39°C below pH 3)20, and Menger’s peptidase model (Figure 1-3) (t1/2 8 
minutes at 21.5°C at pD 7.05)21. 
   
COOH
COOH
C N
O
 
Figure 1-3: Menger's peptidase model 
 
The amide hydrolysis is initiated by proton transfer from the adjacent 
carboxyl group to the amide, followed by intramolecular nucleophilic attack 
of the carboxylate ion to the carbonyl carbon atom of amide22.  This is 
illustrated following (Figure 1-4) using an example of the hydrolysis of N-
methylphthalamic acid which gives the corresponding anhydride and 
amine molecule23.  The anhydride subsequently hydrolyses with water. 
 
The hydrolysis reaction is at a maximum rate when the acid group is in an 
un-ionised -COOH form (c.f. in the ionised -COO- form), and slows with 
degree of ionisation as the pH increases. 
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Figure 1-4: Hydrolysis of N-methylphthalamic acid 
    
1.3.1 Glüsenkamp’s Investigations 
Glüsenkamp and co-workers had synthesised a class of bicyclic 
carboxyamides 1-9b (Figure 1-5) differing with respect to substitution 
patterns and exo-endo geometry22.  They used N-methyltryptamine and 
bicyclic anhydrides as precursors for these acid labile amides.  The highly 
substituted bicyclic anhydrides were used as they offer great structural 
varieties with potential for rate enhancements, and might be used as tools 
for masking and modifying therapeutic agents containing the amine 
functionalities. 
 
The cleavage rate of the amide bonds was shown to be proportional to the 
degree of protonation of the neighbouring carboxyl group, which is related 
to the correspondent structure-related dissociation constants (Ka)
19-21.  
Thus the correlation between cleavage rates and substitution patterns 
were studied by performing the kinetic experiments under identical 
reaction conditions but at different pH values (Table 1-1).   
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1a, 1b; X=O; R=CH2-O-COPh; 2, 3-exo; 5, 6-CH 
2a, 2b; X=O; R=CH2-O-COPh; 2, 3-exo; 5, 6-CH2 
3a, 3b; X=O; R=CH2-O-COPh; 2, 3-endo; 5, 6-CH 
4a, 4b; X=O; R=CH2-O-COPh; 2, 3-endo; 5, 6-CH2 
5a, 5b; X=O; R=H; 2, 3-exo; 5, 6-CH 
6a, 6b; X=O; R=H; 2, 3-exo; 5, 6-CH2 
7a, 7b; X=CH2; R=H; 2, 3-endo; 5, 6-CH 
8a, 8b; X=CH2; R=H; 2, 3-endo; 5, 6-CH2 
9a, 9b; X=CH2-CH2; R=H; 5, 6-CH2 
 
Figure 1-5: Glüsenkamp's bicyclic anhydrides (a, left) and their corresponding N-
methyltryptamine derivatives (b, right) as model amides 
 
Table 1-1: t1/2 of the N-methyltryptamides 1b-9b 
Compound pKa t1/2[min] 
(pH 5.0) 
t1/2[min] 
(pH 6.0) 
t1/2[min] 
(pH 7.0) 
1b 4.6 67 336 2340 
2b 4.6 17 106 840 
3b 4.7 312 1560 12480 
4b 4.5 155 930 7440 
5b 4.5 31 159 1260 
6b 4.6 10 52 420 
7b 5.4 2 13 102 
8b 5.4 2 13 102 
9b 5.9 0.3 0.5 2.4 
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In the study the cleavage rates (kobs) were determined by high 
performance liquid chromatography (HPLC) and ultraviolet spectroscopy 
at 37°C and 150 mM salt concentration at different pH values; the half-
lives (t1/2 = 0.693/kobs) were calculated according to pseudo-first order 
kinetics. 
 
The data revealed that all oxygen-bridged ring systems exhibit comparable 
pKa values of 4.5-4.7.  On the other hand, the amides 7b and 8b show pKa 
values of 5.4, and the amide 9b (Figure 1-6) exhibits an unusual high 
value of 5.9.  The comparison of half lives (t1/2) clearly shows a strong 
structure-dependent lability.  Glüsenkamp thus summarised that, in 
general: 
1. Exo-compounds are more reactive than their corresponding endo-
compounds. 
2. Saturated, oxygen-bridged structures are generally about 2-3 times 
more labile than the corresponding unsaturated compounds 
(compound 6b vs. 5b). 
3. Substitution of the oxygen by an ethane bridge (-CH2-CH2-) results 
in a dramatically increased cleavage rate.  The carboxyamide 9b 
exhibits an extremely short half-life of only 0.3 minutes at pH 5.0, 
and 2.4 minutes at pH 7.0. 
  
O
O
N
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CH3
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Figure 1-6: Glüsenkamp's acid amide 9b - high hydrolysis rate 
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1.4 Previous work 
Prior to the current master’s project, a preliminary short undergraduate 
project24 was carried out in our laboratories using a secondary amine.  The 
acid-amide prepared was not obtained in a pure form due to time 
constraints, but it was used as an impure salt for a preliminary assessment 
of pH-rate profile for the hydrolysis reaction.   
 
The preliminary work was carried out with the following aims: 
1. To synthesise a ring-unsaturated analogue of Glüsenkamp’s most 
reactive acid amide 9b 
2. To determine the hydrolysis rate of the synthesised compound and 
its pH-sensitivity in hydrolysis reaction.  
 
For the acid-amide synthesis (Figure 1-7), N-methylaniline was chosen as 
the secondary amine, whereas the bicyclic anhydride was prepared from 
maleic anhydride and 1,3-cyclohexadiene via a Diels-alder reaction.  
Reaction of the endo-bicyclic anhydride with the lithium amide gave an 
impure lithium salt of the acid-amide (analysis by nuclear magnetic 
resonance spectroscopy). 
  
Although a pure product could not be obtained within the shortest time-
frame of the study, the impure salt was used for preliminary assessment of 
pH rate profile of its cyclisation to release N-methylaniline (Figure 1-8).  
This was established by measuring its rate of reaction at different pH 
values (in the range of pH 5.7 to 7.2).  This was done by ultraviolet/visible 
(UV/Vis) scanning after addition of aliquots of an aqueous solution of the 
acid-amide salt 6 to the buffered phosphate aqueous solutions at 30°C. 
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Figure 1-7: Synthetic route to acid-amide 
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Figure 1-8: Cyclisation of acid-amide to release amine 
 
The increasing absorbance at 238 nm and 288 nm was consistent with the 
formation of N-methylaniline, and the absorbance values at 238 nm were 
read off at certain time intervals.  From these, a graph of log10(A∞-At) 
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against t was plotted, and the first order rate constants and half-lives 
calculated.  The results, summarised in the following table and graph, are 
however subject to uncertainty because of the known lack of purity of 
reactant. 
 
Table 1-2: Rate constants and half lives of acid amide at different pH  
pH Rate Constant 
k (min-1) 
t1/2 (min) 
7.2 0.012 56 
6.4 0.039 18 
6.0 0.083 8 
5.8 0.108 6 
5.7 0.119 6 
 
 
Figure 1-9: pH-rate profile of acid-amide 
 
From the graph, with decreasing pH the reaction rate increases, indicating 
that the amide cyclisation reaction is faster at lower pH compared to high 
pH values. 
   
The reaction half life was about 56 minutes at pH 7.2, and 6 minutes at pH 
5.7.  The results seemed to have attained the initial aim of releasing N-
methylaniline at a rate differential significantly in favour of pH 6 over pH 7; 
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but more thorough investigations with pure acid-amide would be needed to 
obtain more reliable results.  
 
1.5 Project Aim 
For the directed study research, the acid-amide was only synthesised in its 
salt form, and the product was not purified to give accurate rate 
measurements with pH.  This synthesis difficulty seemed to be associated 
with the use of sterically crowded secondary amine (N-methylaniline), so 
for the current study it was replaced with a primary aromatic amine, p-
methoxyaniline.   
 
Thus, the goal of the current master’s project was to synthesise the acid-
amide in its un-ionised form, purify it, and to obtain a full pH-rate profile for 
its cyclisation.  In the event purity problems required it to be synthesised 
by an indirect route through the corresponding imide. 
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2 Results and Discussions 
2.1 Preparation of endo-bicyclo[2.2.2]octa-5-ene-2,3-
dicarboxylic anhydride 3 
This synthesis is by the well-known Diels-Alder cycloaddition pathway 
reported in many research papers25-28. In this project, the method of 
preparing the endo-anhydride was adapted from Birney et al.28 
O
O
O
+
1 2
O
O
H
H
O
3
 
Figure 2-1: Synthesis of endo-bicyclo[2.2.2]octa-5-ene-2,3-dicarboxylic anhydride 
 
The words endo and exo are used to indicate relative stereochemistry 
when referring to bicyclic structures.  A substituent on one bridge is said to 
be exo if it is anti (trans) to the larger of the other two bridges and is said 
to be endo if it is syn (cis) to the larger of the other two bridges29 (Figure 
2-2).   
 
R
R
1-carbon bridge
2-carbon 
bridge
endo substituent
(syn to larger bridge)
exo substituent 
(anti to larger bridge)
 
Figure 2-2: Definition of endo and exo substituent 
 
The diene (1,3-cyclohexadiene) and dienophile (maleic anhydride) 
preferentially line up to form the endo product, rather than the alternative 
exo product, because of the more favourable orbital overlap between 
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diene and dienophile when the reactants lie directly on top of one another 
with the electron-withdrawing substituent on the dienophile underneath the 
diene29 (Figure 2-3).  This stereoselectivity is one of the unique features of 
the Diels-Alder reaction, but is lost at higher temperatures when there is a 
chance of reversibility occurring, and the more stable exo product may be 
formed. 
 
O
O
O
H
H
 
Figure 2-3: Formation of the endo-product via Diels-Alder cycloaddition reaction 
 
Birney et al. recrystallised the crude endo-anhydride from methanol and 
obtained a product yield of 82%.  However, when the Birney method was 
attempted, less than 30% of the expected yield was obtained, and the 
infrared (IR) spectrum suggested the presence of an acid-ester group.  
One possible reason for this could be that methanol reacted with one of 
the C=O carbonyl groups of anhydride to give an acid-ester, thence 
lowering the yield of pure anhydride that recrystallised out from methanol. 
 
The crude endo-anhydride was later recrystallised from dichloromethane 
instead of methanol.  Even though the yield was not as high as the 82%-
yield reported by Birney, the acid-ester peak was no longer observed on 
IR spectrum, and the IR analysis and melting point determination 
confirmed that the desired endo-bicyclic anhydride had been successfully 
prepared.   
 
In the following sections, the endo stereochemistry of reactants and 
products is for simplicity not indicated but should be assumed. 
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2.2 Attempted syntheses of acid-amide using N-methylaniline 
2.2.1 Introduction   
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Figure 2-4: Synthesis route to acid-amide 7 
23 
 
Figure 2-4 shows an initial attempt to prepare a secondary acid-amide 7 
using N-methylaniline.  The amide salt 6 was prepared by first ionising N-
methylaniline 4 with butyllithium, after which the product 5 was reacted 
with endo-anhydride 3 to give 6.   
 
Previous work done by Menger et al. on Kemp’s acid amides suggests 
that acid-amide 7 may be too reactive to isolate in the neutral form21.  
Meanwhile, an earlier study24 had also indicated that a pure product of 6 
was difficult to prepare.  Therefore, the neutralisation step (6  7) was not 
carried out.  Instead, an attempt was made to “trap” 6 as an ester which 
could be purified and then hydrolysed to get a pure sample of a secondary 
acid-amide (Figure 2-5). 
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Figure 2-5: Esterfication of acid-amide salt 6 
 
The main reason for using N-methylaniline was that most cytotoxins used 
in anticancer treatments today are arylamines but not aliphatic amines21, 30.  
Moreover, N-methylaniline is a secondary amine so the product cannot 
form an imide in an unwanted side-reaction.  If a primary amine like aniline 
is used, the acid-amide would be formed but might also form some imide 
in competition with hydrolysis31 (Figure 2-6).  This would subvert the 
reason for forming the acid-amide in the first place, i.e. to release the 
amine by hydrolysis reaction. 
     
When the amide ester 8 was not successfully prepared, another attempt 
was made to prepare acid-amide 7 directly from endo-anhydride 3 in 1,4-
dioxane, a high boiling point solvent (Figure 2-7). 
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Figure 2-6: Formation of imide due to use of a primary amine 
 
O
O
N
CH3
OH
O
O
O
3 7
1,4-dioxane
N-Methylaniline
 
Figure 2-7: A direct synthesis of acid-amide 7 from endo-anhydride 3   
 
2.2.2 Attempted synthesis of amide ester 8 
Acid amide 6 was reacted with methyl iodide and K2CO3 in acetone (dried 
with 4 Å molecular sieves prior to use).  K2CO3 does not dissolve in 
acetone but forms potassium iodide, KI, over time as iodide substitution 
occurs.  K2CO3 acts as a base and is expected to exchange Li
+ for K+, 
thus making the carboxylate ion COO- more reactive.  However, after the 
reaction was left for more than 24 hours, there were no signs of products 
being formed by thin-layer chromatography (TLC).  NMR and IR analysis 
could not confirm the formation of 8.  The same applied in a second 
attempt in which the acetone was replaced by dimethylformamide (DMF) 
as the reaction solvent. 
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2.2.3 Direct synthesis of acid-amide 7 
1,4-dioxane is classified as an ether, but more polar in structure and with a 
high boiling point.  Prior to use, it was treated with activated alumina which 
acts as a water-adsorbent to ensure the solvent was water-free and 
removes any peroxide impurities. 
   
After the reaction was reflux for 16 hours, no product seemed to be formed 
as shown by TLC analysis.  Dimethylaminopyridine (DMAP) was later 
added to act as a base catalyst to aid the esterification process.  Even so, 
no reaction was observed.  Steric factors are assumed to thwart the 
reaction of the secondary amine.   
 
2.3 Attempted synthesis of acid-amide using p-methoxyaniline 
2.3.1 Introduction 
As the attempt of preparing an acid-amide using N-methylaniline had not 
been successful, the synthetic plan was changed to replace N-
methylaniline with p-methoxyaniline, a less sterically hindered primary 
amine molecule.  However, the synthesis of the primary acid-amide was 
not successful as a pure compound could not be obtained.  The plan had 
thus again to be diverted in this case to synthesising an imide, purifying it 
and then opening the imide ring in KOH to get a pure acid-amide 
carboxylate salt solution which could be used for kinetic analyses by 
adding aliquots to lower pH buffer solutions.   
 
2.3.2 Synthesis of acid-amide 9 
p-Methoxyaniline was reacted with endo-anhydride to give crude acid-
amide 9.  The endo-anhydride was difficult to dissolve in ether at room 
temperature; hence it was dissolved with heating.  IR analysis of the 
product gave carbonyl peaks at 1731 and 1649 cm-1 which are consistent 
with the presence of a carboxylic acid and an amide group, respectively.  
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Absorbance at 1780 cm-1 however indicated presence of some residual 
anhydride.  
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Figure 2-8: Synthesis of acid-amide 9 
 
The reaction of crude 9 was studied in 0.1 mol L-1 phosphate buffer 
solution (4:1 H2PO4
-/HPO4
2-) at pH 6.4 by repetitive UV (ultraviolet) 
scanning to completion.  The UV spectrum showed a decreased 
absorbance at 250 nm, indicating that acid-amide 9 was being hydrolysed.  
Moreover, an increase in absorbance at 220 nm and 290 nm was also 
observed, which was consistent with the formation of endo-anhydride 3 
and p-methoxyaniline, respectively. 
  
The pH of the solution in the cell at completion of reaction was later raised 
to 11.8 by adding KOH solution (0.01 mol L-1) to the cell content; this was 
aimed to observe any ring-opening reaction from imide that might have 
been formed.  The UV spectrum showed no sign of absorbance change, 
which is indicative of either no imide having been formed, or the imide 
reaction was too fast to be observed at this pH.  To check for this, the pH 
was lowered again to 6.8 by adding H2PO4
- solution to the cell content.  It 
was expected to see no change in the absorbance, but when this solution 
was monitored again by repetitive UV scanning, it showed the same 
reaction observed previously for amide hydrolysis.  This is indicative of 
amide formation from imide at pH 11.8, and the amide itself later being 
hydrolysed to release amine when the pH was lowered to 6.8.  This 
suggests that the solution at pH 6.4 must have had some imide present 
along with anhydride and amine.  The imide was either formed from amide 
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at pH 6.4 (along with hydrolysis reaction), or there was possibly some 
imide present in the prepared amide, in which the imide was unreacted 
until the pH was raised to 11.8 when it reacted to give amide. 
 
The pH was raised again to 10.4 by adding KOH to the cell solution to try 
to detect the imide opening reaction.  The UV spectrum did not show any 
sign of absorbance change, suggesting that there was no imide left for 
reaction at this stage, or the imide reaction was too fast or too slow to be 
detected.        
   
2.3.3 Synthesis of imide 10 
At this stage syntheses of pure acid-amide had not been successful, so an 
attempt to prepare an imide 10 (Figure 2-9) was made. 
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Figure 2-9: Synthesis of imide 10 
 
The intention was that this imide, once synthesised and purified, could be 
converted to its acid-amide analogue by placing it in an alkaline solution in 
which the imide opens up to give the corresponding acid-amide as its 
carboxylate salt (Figure 2-10). 
 
The reaction carried out in dry acetonitrile over 16 hours gave a 74% yield 
of imide. 
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Figure 2-10: Conversion of imide to corresponding acid-amide 9 
 
The reaction of purified 10 was studied in 0.002 mol L-1 KOH solution 
which was monitored by repetitive UV scanning to completion.  The 
spectrum showed an absorbance increase at 250 nm and gave an 
isosbestic point at 232 nm, which were indicative of formation of amide 
from the imide 10. 
   
At completion of the reaction, the pH of the cell solution was raised to a 
higher pH (exact pH not measured) by adding a few drops of 0.01 mol L-1 
KOH solution to it.  The UV spectrum suggested that more amide was 
formed from imide as the absorbance at 250 nm was further increased 
and the spectrum gave the same isosbestic point at 232 nm.  This 
suggested that the reaction is in equilibrium which is dependent on the 
hydroxide concentration. 
   
This was again confirmed when the pH of the cell solution was afterwards 
lowered to 10.9 by adding phosphate buffer solution.  The reversal of 
amide to imide was observed as the absorbance was decreasing at 250 
nm and the UV spectrum gave the same expected isosbestic point at 232 
nm.  This is consistent with the compound prepared being the desired 
imide 10, which gave rise to amide at high pH. 
   
The identity of imide 10 was also later confirmed by IR and NMR 
spectroscopies.  The NMR spectrum of imide 10 is shown in Appendix B. 
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2.4 Kinetic Studies of reversible ring-opening of imide 10 
2.4.1 Rate constants for forward and reverse reactions 
In this study the synthesised imide 10 was placed in alkaline solution 
which caused the imide ring to open up to give acid-amide as the 
carboxylate 9 (Figure 2-10). 
 
The reaction studied was: 
   
Therefore: 
Rate forward = kf [imide] [OH
-] 
Rate reverse = kr [amide carboxylate] (assuming it is a first order reaction 
with no effect from [OH-]), where kf is the second order rate constant of 
forward reaction, and kr is the first order rate constant of reverse reaction.  
 
The observed rate constant, kobs, of a reaction in such an equilibrium is the 
sum of forward and reverse rate constants32, ie. at any fixed [OH-]: 
kobs  = kf [OH
-] + kr 
 
In the current study, a number of reactions over a range of [OH-] were 
monitored and first order rate constants, kobs, were obtained.  By plotting 
the graph of kobs versus [OH
-] (Figure 2-11), kf and kr were determined 
experimentally from the gradient and y-intercept, respectively, of the 
apparent linear graph. 
 
Table 2-1: kobs values obtained at various [OH
-
] 
[OH-] 
(mol L-1) 
k 
(min-1) 
0.0200 1.47 
0.0160 1.26 
0.0120 0.988 
0.0100 0.814 
0.0080 0.561 
0.0060 0.461 
0.0040 0.348 
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The percentage errors of kobs (approximately 10%) were estimated 
manually by plotting the maximum and minimum slope – determined from 
the errors of At and A∞ values (each ±0.002) – on the graphs of log10(A∞-At) 
against t.  One of these graphs is shown in Appendix C. 
 
 
Figure 2-11: Graph of kobs against [OH
-
] 
 
Therefore, it could be determined from the plot that kf (conversion of imide 
to amide carboxylate) was 74±16 L mol-1 min-1.  The error was estimated 
from the error of slope (Appendix C).  The intercept is a negative value (-
0.05 min-1) but the experimental error from extrapolation is large (±0.12 
min-1), so more investigations would be needed to determine the value of 
intercept (kr) if it is non-zero.    
 
All of the above calculations are based on an assumption that the reverse 
reaction is pH-independent: kobs = kf [OH
-] + kr. 
However, if the reverse reaction was somehow also dependent on [OH-], 
then: 
kobs  =  kf [OH
-] + kr [OH
-] 
 = (kf + kr) [OH
-] 
 
This would end up giving a linear plot through the origin and this cannot be 
excluded from the data in Figure 2-11. 
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But, since the equilibrium constant is given by the ratio of forward to back 
reaction rate constants, it would in this case be given by:  
K =  = . 
This requires that the position of equilibrium is independent of hydroxide 
concentration, but this is inconsistent with earlier observations (section 
2.3.3) that the extent of reaction of imide increased with increasing pH. 
 
A third possibility is that the reverse amide carboxylate to imide reaction 
has two terms, one first order, the other second order in [OH-]: 
Rate of reverse reaction = kr(1) [amide carboxylate] + kr(2) [amide 
carboxylate] [OH-], whereby: 
kobs  =  kf [OH
-] + kr(1) + kr(2)[OH
-] 
 = (kf + kr(2)) [OH
-] + kr(1) 
 
This would give a non-zero intercept but the gradient would now represent 
the sum of kf and kr (2). 
   
Irrespective of whether the ring opening process of imide 10 in this study 
is of any of the three cases, the pH-dependence of the reverse imide-
formation reaction itself needs to be studied independently  with the amide 
carboxylate as reactant at lower pH, where [OH-] is too low to promote the 
forward imide opening reaction.  If the reverse reaction is independent of 
[OH-] then only the first of the above three cases would be consistent. 
 
2.4.2 Equilibrium Constant, K 
An accurately determined value of the rate constant for the reverse imide-
forming reaction of amide carboxylate would also allow calculation of an 
accurate value for the equilibrium constant, K, using the value for kf from 
section 2.4.1. 
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The other way to independently determine the value of K is from 
absorbance changes rather than rates.  K could be calculated from the 
final absorbance (A) values of the individual runs at different hydroxide 
concentrations as the following analysis shows. 
 
If: 
Ai = Initial absorbance at zero (mixing) time; 
At = Absorbance at end of reaction for that particular [OH
-]; 
A∞ = Absorbance for complete conversion to amide as would occur at very 
high [OH-]. 
 
And if: 
∆At = At – Ai; 
∆A∞ = A∞ - Ai. 
 
Then:  
∆At is directly proportional to the amount of amide formed for this [OH
-]; 
∆A∞ is directly proportional to 100% conversion of imide to acid-amide; 
 = fraction of the amide conversion at certain hydroxide 
concentration; 
(∆A∞ - ∆At) is directly proportional to the amount of amide that is yet to 
form, i.e. directly proportional to the amount of imide. 
 
Therefore, assuming again that the reaction is independent of [OH-] in the 
reverse directions:  
  
 
By rearranging the formula: 
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Therefore, by plotting  versus , the equilibrium constant, K, can 
be calculated from the values obtained from the y-intercept and gradient of 
the linear graph.  This would allow the equilibrium constant to be 
determined without taking amide conversion to completion in case there 
are some unavoidable experimental errors (e.g. not knowing at which 
hydroxide concentration the amide conversion is complete). 
 
It was intended to apply this analysis once it had been developed in 
principle to the kinetic runs at varying [OH-] but the reactions had been so 
fast in relation to the time taken to mix solutions and take early 
absorbance readings that extrapolation of first-order kinetic analysis plots 
to zero (mixing) time was too inaccurate to give reliable zero time 
absorbance values.  Plots based on the above linear relationship were 
subject to too large error to be useful.  Probably better data could have 
been obtained for this purpose at lower [OH-] for which the extrapolation to 
zero time A would have been more reliable but insufficient time prevented 
this additional study.  In any case, accurate values for kr as determined in 
the next section using amide carboxylate as reactant allowed an accurate 
value for K to be established. 
 
2.5 Kinetic studies towards acid-amide 9 using buffer 
solutions 
2.5.1 Introduction 
Since it has been shown that acid-amide 9 can be successfully obtained 
from imide 10, the pH-rate profile of the reaction of 9 can thus be 
established by reacting 9 at different lower pH values.   
 
We are primarily interested in the potential of the drug model system to 
release amine (i.e. hydrolysis reaction) more rapidly at pH 6.5 (tumour 
tissues environment) than at pH 7.4 (normal tissues environment).  In the 
pH region of primary interest, both the ionised and neutral forms of acid-
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amide will be present (in proportions differing with pH).  Thence a kinetic 
analysis is required to obtain rate constants for the reaction of both 
species, of which the products would need to be determined alongside the 
kinetic analysis.  
 
It is already known from the previous sections that the ionised amide gives 
only the imide product; it does not hydrolyse as the amide solution at high 
pH is quite stable.  Ideally for prodrug application the neutral acid-amide 
would give hydrolysis only, and earlier studies with related systems33, 34 
suggest this may be so, but a check that the acid-amide in neutral form 
gives no imide as well would be helpful in assessing its prodrug potential. 
 
From kinetic analysis of the higher pH (given by hydroxide solutions) study 
on imide opening to amide, a rate constant for the reverse amide  imide 
reaction might have been obtained (section 2.4) but the experimental 
error was too large.  A value is needed through direct study at a lower pH 
range of 9-10 where the acid-amide remains fully ionised but where [OH-] 
is too low for significant ring opening of imide to occur.  This study is 
covered in section 2.5.2.  The obtained rate constant would contribute to 
overall kobs down in pH until the acid-amide is fully in neutral form. 
 
The reaction of the neutral form of acid-amide would contribute to the 
overall kobs which is suspected to increase with decreasing pH as more 
neutral form is present.  At sufficiently low pH, the acid-amide will be in 
fully neutral form and further reduction in pH will have no effect on the rate 
and rate constant.  If the reaction is not too fast to be measured at this low 
pH, a plateau should be reached in the pH-rate profile from which the 
limiting rate constant, klim, can be obtained directly, but if the reaction is 
too fast the data may still be analysed to obtain klim and pKa.  This is 
covered in section 2.5.3. 
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2.5.2 pH rate profile of ionised acid-amide 
The kinetic analysis of ionised acid-amide was conducted to confirm the 
rate constant for the reformation of imide from amide which was 
determined in section 2.4.  This was done at a lower pH range (pH 9-10) 
by means of a series of carbonate buffer solutions.   
 
The kinetic analysis was conducted on a Hewlett Packard Agilent 8453 
UV/Vis spectrophotometer.  The acid-amide 9 was prepared in solution by 
adding imide 10 to 0.1 mol L-1 KOH solution.  Samples were then added to 
various carbonate buffer solutions at 30.0°C and the kobs values and their 
standard deviations (sd) were calculated, by the Agilent Chemstation 
software, using the absorbance values obtained at 247 nm (λmax of acid-
amide). 
 
The kobs values across the pH range of 9-10 were apparently constant 
within experimental error (Table 2-2) and it appears that these rate 
constant values are independent of the hydroxide concentrations.  The 
average kobs value was calculated to be 0.067±0.011 min
-1.  This indicates 
that the y-intercept value (-0.05±0.12 min-1) from Figure 2-11 is actually a 
positive value, hidden by the large experimental error. 
 
Table 2-2: kobs values obtained within the pH range of 9-10 
pH 
kobs 
(min-1) 
standard deviation 
(min-1) 
9.91 0.074 0.005 
9.43 0.065 0.005 
9.34 0.064 0.002 
9.32 0.062 0.005 
9.06 0.071 0.011 
 
From section 2.5.3 below similar values for kobs were obtained using 
malonate buffer solutions at the lower pH 7.5-8.5, indicating that the 
protonation of hydrolysable neutral acid-amide is negligible at this pH 
range as well. 
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Figure 2-12: An example of the UV/Vis repetitive scanning spectrum of 1:1 
carbonate buffer (pH 9.43) 
 
A previous study on an imide ring-opening equilibrium promited by OH- 
was carried out by Shafer et al. on N-methylphthalimide23 (Figure 2-13).  
This was carried out at 37°C and ionic strength, µ, of 0.2.  A plot of kobs 
versus [OH-] gave kf, from the slope of the plot, as approximately 1800 L 
mol-1 min-1, which was considerably higher than the kf value calculated in 
the current study as 74 L mol-1 min-1.  That is, imide 10 is much more 
stable to ring-opening than the aromatic imide reported by Shafer et al.   
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N-Methylphthalimide N-Methylphthalamate  
Figure 2-13: Imide ring-opening equilibrium reaction studied by Shafer et al.
23
 
 
The equilibrium constant (K = kf/kr) for ring-opening is correspondingly 
much higher for the aromatic imide.  Shafer et al. reported a K value of 
4x107 L mol-1.  In contrast, from the current study the K was calculated to 
be only 1100 L mol-1.  The value of kr (0.067 min
-1) for imide 10 is about 15 
times larger at 30°C than that for the aromatic imide (0.0045 min-1) at 37°C. 
These differences suggest that the aromatic imide is much more prone to 
ring-opening and less to ring closure, reflecting perhaps greater strain in 
the ring-closed system in which the aromatic ring-fused bond is shortened 
compared to the aliphatic bond in the current molecule. 
   
Ring-closure to form anhydride as part of the hydrolysis reaction at lower 
pH (see section 2.5.3) may equally be faster for the aliphatic systems, 
which would enhance their potential as anti-cancer prodrugs. 
 
However, the N-substituent differs between the two molecules (methyl 
versus p-methoxyphenyl) and there are doubtless contributions to the 
differences resulting from electronic effects on rates and equilibrium 
position.   
 
2.5.3 pH rate profile incorporating neutral acid-amide 
The acid-amide 9 solution prepared in 0.1 mol-1 KOH as described in 
section 2.5.2 was reacted in the following buffer solutions at 30.0°C: 
 Phosphate buffer – pH range: 5.5-7.5 
 Malonate buffer (second ionisation) – pH range: 4.5-8.5 
 Malonate buffer (first ionisation) – pH range: 2-4 
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The kobs values and their standard deviations were again calculated by the 
Agilent Chemstation software, and a graph of kobs against pH was then 
plotted to obtain the pH-rate profile of the acid-amide. 
 
Table 2-3: kobs values obtained at various pH 
pH 
kobs 
(min-1) 
pH 
kobs 
(min-1) 
2.33 0.5368 5.90 0.1253 
2.77 0.5068 6.02 0.1126 
3.21 0.4576 6.10 0.1042 
3.44 0.4311 6.45 0.0926 
3.64 0.4213 7.06 0.0722 
3.86 0.4122 7.49 0.0647 
4.65 0.3395 8.11 0.0713 
4.82 0.3103 9.06 0.0710 
5.32 0.2231 9.32 0.0619 
5.59 0.1724 9.34 0.0642 
5.67 0.1613 9.43 0.0644 
5.84 0.1306 9.91 0.0742 
  
 
Figure 2-14: pH rate profile established for acid-amide 9 [30.0°C, µ 1.00 (KCl)].  The 
best fit line is based on equation (7) (see later).   
 
The rate data within the pH 3-7.5 range were analysed according to a 
modified form of the following equation derived by Menger and Ladika21  
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where Ka is the carboxyl ionisation constant, and klim is the limiting rate 
constant at 100% conjugate acid. 
 
The modification was needed to take account of the contribution to rate of 
higher pH reaction of amide carboxylate to form imide. 
 
For the equilibration of acid-amide and its amide carboxylate anion: 
 
COOH
CONHAr
COO
-
CONHAr
Let this fraction = f
(may either hydrolyse
or form imide)
Let this fraction = 1-f
(can only form imide)
Ka
 
 
If klim is the lower pH plateau rate constant (100% of neutral acid-amide, 
excluding any [H+] catalysis), and klow is the higher pH plateau rate 
constant for amide carboxylate (can only form imide), then: 
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Substituting (4) into (3): 
 
  
 
By inverting (2): 
 
  
 
Substituting (5) into (6): 
 
  
  
 
  
 
This requires an independently (higher pH) calculated value for klow (taken 
to be 0.067 min-1, see section 2.5.2), whereby klim can be obtained from 
the intercept and thereby, Ka from the gradient of a plot of 1/(kobs-klow) 
against 1/[H+]. 
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Figure 2-15: Graph of 1/(kobs-klow) vs 1/[H
+
] 
 
Applying this to the current data, the straight line graph (Figure 2-15) 
allows the values of klim and pKa to be calculated, which turned out to be 
0.44±0.03 min-1 and 5.1±0.4, respectively.  These values when applied to 
equation (7) provide the calculated line of best fit in Figure 2-14.  The 
deviation at low pH, which is outside the range of interest for prodrugs, 
may be a result of H+ catalysis but time limitation has prevented further 
study on this. 
 
The errors estimations for klim and pKa values are showed in appendix D. 
 
Proof that the low pH reaction of neutral acid-amide is hydrolysis only and 
not imide formation was obtained by carrying out a one-off reaction of 
acid-amide in buffered malonate solution at pH 3.9, monitoring reaction to 
completion, then raising pH to 11.1 by addition of a calculated amount of 
K3PO4 to reference and sample cells.  At this pH, the rate of ring-opening 
of any imide present would have a half-life of about 10 minutes, and the 
equilibrium constant for the reaction is around 1 from the data in sections 
2.4.1 and 2.4.2.  Therefore a rapid reaction of around 50% of any imide 
present would be easily detected by increased absorbance at 247 nm 
(λmax for acid-amide).  No change was observed over 18 hours, indicating 
that the neutral acid-amide gives hydrolysis only. 
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In the current study, acid-amide 9 was prepared as an analogue of 
Glüsenkamp’s acid-amide 9b (Figure 1-6).  Glüsenkamp et al.22 reported a 
pKa value of 5.9 and an extraordinarily high klim value of 6.93 min
-1.   This 
was carried out at 37°C and 150 mM salt concentration.  These values 
were considerably higher than the acid-amide 9 of the current study, of 
which the pKa and klim values were determined to be 5.13 and 0.44 min
-1 
respectively.  Glüsenkamp’s acid-amide was however a tertiary aliphatic 
one and this would be expected to influence rate significantly even if not to 
pKa.     
 
Kluger and Lam34, on the other hand, also reported a similar acid-amide 
molecule, differing only in having a 1-carbon bridge at C-1,4 positions 
(Figure 2-16), in contrast to a 2-carbon bridge for the current acid-amide 9 
molecule (Figure 3-4).   
O
O
H
N
OH
OCH3  
Figure 2-16: Kluger's acid-amide
34
 
 
The hydrolysis reaction of the above compound was carried out at an ionic 
strength of 1.0 with KCl, and at a temperature of 50°C.  Kluger and Lam 
reported that the hydrolysis reaction gave a pKa value of 5.0 and a 
hydrolysis rate of 0.87 min-1.  The acid-amide 9 in the current study shows 
a pKa very similar to Kluger’s and the rate of reaction of the neutral acid-
amide at 30.0°C is about half that of Kluger’s at 50°C.  Direct comparison 
is not possible but the increased bridge size in the molecule does not 
appear to have a significant effect on either pKa or rate, even if the results 
from the study by Glüsenkamp suggest a high sensitivity of both pKa and 
rate to minor structural changes. 
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3 Materials and Methods 
3.1 Materials 
Dry solvents 
Specifically dry solvents including diethyl ether, tetrahydrofuran (THF) and 
dichloromethane were obtained from the solvent purification system. 
 
Nitrogen-saturated, CO2-free distilled water 
This was used for all preparations of buffer solutions used for kinetic 
analyses.  Distilled water was boiled for at least 3 hours, after which it was 
cooled to room temperature while being gently flushed with nitrogen gas.  
Once it was cold and saturated with nitrogen a drying tube with CO2-
adsorbent was attached to the flask to keep the water free of CO2.   
 
3.2 General methods 
NMR Spectroscopy 
All 1H NMR spectral work was performed on either Brüker DRX 300 FT-
NMR (300 MHz) or Brüker DRX 400 FT-NMR (400 MHz) spectrometers 
with deuterated chloroform or deuterated acetone as the solvents.  
Chemical shifts are expressed in parts per million (ppm) and are given in δ.  
1H chemical shifts for the deuterated solvents are referenced as follows: 
CDCl3 - 7.24 ppm; (CD3)2C=O - 2.04 ppm.  Spin multiplicities are indicated 
by the following symbols: s (singlet); d (doublet), t (triplet), m (multiplet), dd 
(doublet of doublets). 
 
Infrared Spectroscopy 
All infrared (IR) spectra were recorded on a Perkin-Elmer Spectrum 100 
FT-IR spectrophotometer over the range of 4500 – 450 cm-1 at 1 cm-1 
resolution.  Samples were either prepared as a KBr disc or run neat 
between two polished KBr discs. 
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Ultraviolet/Visible Spectroscopy 
All UV/Vis studies were conducted either on a Kontron UVIKON 860 
spectrophotometer (wavelength range 180-900 nm) or Hewlett-Packard 
8453 Diode Array spectrophotometer (wavelength range 180-900 nm) 
coupled with the Agilent Chemstation software for kinetic analyses. 
 
Melting points 
Melting points were measured, uncorrected, using a Reichert thermopan 
melting point apparatus.   
 
pH Measurements 
pH measurements were done on Radiometer pHM 240 using a Schott 
Gerate H6180 electrode.   
 
Elemental analysis 
An elemental analysis of imide 10 was performed at the Campbell 
Microanalytical Laboratory, University of Otago, Dunedin, New Zealand. 
   
3.3 Preparation of compounds 
3.3.1 endo-Bicyclo[2.2.2]octa-5-ene-2,3-dicarboxylic anhydride 3 
O
O
O
H
H
 
Figure 3-1: endo-Bicyclo[2.2.2]octa-5-ene-2,3-dicarboxylic anhydride 3 
 
This method was adapted from Birney et al.28.  To maleic anhydride (2; 
1.058 g, 10.8 mmol) was added chloroform (25 mL).  The solution was 
cooled with ice and to this was slowly added 1,3-cyclohexadiene (1; 1.03 
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mL, 11 mmol).  The solution was let warm to room temperature and to 
react overnight in the dark.  The chloroform was then removed in vacuo, 
the residue was recrystallised from dichloromethane, collected and dried 
overnight to yield white needle-like crystals (0.681 g, 35%) of endo-
bicyclo[2.2.2]octa-5-ene-2,3-dicarboxylic anhydride 3.  M.p. 147°C (lit.35 
147°C); IR (in CH2Cl2): 1781 cm
-1 (anhydride C=O). 
 
3.3.2 Attempted synthesis of amide ester 7 
O
O
N
CH3
OCH 3
8
O
O
N
CH3
O-
6
Li
+
CH3I
 
Figure 3-2: Acid-amide salt 6 was prepared, and this was used in an attempt to 
synthesise the amide ester 8. 
 
The acid-amide salt 6 was first prepared.  The method was a repetition of 
the synthesis carried out for directed-study research24.  The reaction was 
carried out in a flask in a chlorobenzene slush bath cooled with liquid 
nitrogen, with nitrogen gas flowing through the reaction flask.  In a 3-neck 
250 mL round bottom flask, N-methylaniline 4 (in 2 mol L-1 cyclopentane; 
0.18 mL, 1.69 mmol) was dissolved in dry ether (10 mL).  Butyllithium 
(0.85 mL, 1.69 mmol) was later added drop wise with stirring to form the 
lithium amide.  Meanwhile, endo-anhydride 3 (0.301 g, 1.69 mmol) was 
dissolved, in a flask heated with warm water, in dry ether (20 mL), and to 
this the lithium amide solution was slowly added with stirring.  The reaction 
mixture was left for 2 hours, after which the slush bath was removed and 
the reaction vessel was left at room temperature overnight in the dark to 
give the ionised acid-amide salt 6. 
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Ether was later removed in vacuo.  The dry residue was dissolved in 
acetone (pre-dried with 4 Å molecular sieves), and to this was added 
methyl iodide (0.50 mL; 10 times excess).  Oven-dried potassium 
carbonate (K2CO3; 0.117 g, 0.5 mol equiv.) was later added to the solution 
with stirring, and the reaction was monitored by TLC (25% ether/hexane).  
IR (in CH2Cl2): 1782 cm
-1 (anhydride C=O); 1635 cm-1 (amide C=O), 1595 
cm-1 (aromatic and aliphatic C=C).   
 
The solids were filtered, and acetone was removed in vacuo to leave the 
product in solid form for analyses. 
 
The IR samples were prepared by dissolving a small amount of product in 
minimal amount of dichloromethane, which was then transferred to a KBr 
cell and analysed.  The IR spectrum showed a strong peak at 1635 cm-1, 
indicating the presence of an amide group.  However, a weak peak of 
residual anhydride at 1782 cm-1 was also observed and there was no sign 
of an ester carbonyl stretch (1730-1750 cm-1). 
   
NMR samples were prepared by dissolving a small amount of product in 
CDCl3.  The NMR spectrum also could not confirm the formation of amide 
ester 8 as the peak of amide methyl proton (C(O)NCH3) was not found on 
the spectrum. 
 
The attempted synthesis of 8 was repeated using a different solvent 
dimethylformamide (DMF) with heating for the attempted methylation 
reaction.  However, the TLC analysis again showed no sign of product 
formation. 
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3.3.3 Attempted direct synthesis of acid-amide 7 
O
O
N
CH3
OH
7
 
Figure 3-3: Acid-amide 7 
 
endo-Anhydride 3 (0.102 g, 0.57 mmol) was dissolved in peroxide-free 
1,4-dioxane (5 mL, treated by activated alumina (Brockmann, Grade II)), 
and to this was added quickly N-methylaniline (0.06 mL, 0.57 mmol).  An 
extra 10 mL of 1,4-dioxane was added before the mixture was left to reflux 
overnight, and the reaction was monitored by TLC (20% ethyl 
acetate/diethyl ether). 
 
No reaction was observed from the TLC plate, thus dimethylaminopyridine 
(DMAP, 0.007 g, 0.057 mmol) was added to the solution and the reaction 
was continued and monitored by TLC.  After an overnight reaction, the 
TLC showed no formation of product.   
 
3.3.4 Attempted synthesis of acid-amide 9 
O
O
H
N
OH
OCH3
9
 
Figure 3-4: Acid-amide 9 
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p-Methoxyaniline (or more commonly known as p-anisidine) is toxic and 
can cause blood damage upon oral ingestion, inhalation or skin contact.  If 
heated strongly, it may release very toxic fumes of nitrogen oxides36.  Prior 
to use, it was purified by recrystallising from activated charcoal. 
 
p-Methoxyaniline (0.213 g, 1.73 mmol) and endo-anhydride (0.308 g, 1.73 
mmol) were dissolved in dry ether in separate flasks (endo-anhydride was 
first dissolved with heating) before the two were combined together.  
Precipitate was immediately formed, but the reaction was left overnight 
with stirring and monitored by TLC (20% ethyl acetate/diethyl ether), until 
the disappearance of reactant was observed on the TLC plate.  The 
precipitated solid was filtered, dried in vacuo, and later recrystallised from 
ether/CH2Cl2 mixture solution to yield crude 9 (0.190 g, 36%).  M.p. 138°C.  
IR (in CH2Cl2): 1780 cm
-1 (anhydride C=O), 1731 cm-1 carboxylic acid 
C=O), 1649 cm-1 (amide C=O).   
 
Even though the amide peak was observed, the IR spectrum still showed 
an anhydride peak at 1780 cm-1, suggesting the impurity of 9 even after 
the recrystallisation reaction. 
 
3.3.5 Synthesis of imide 10 
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Figure 3-5: Imide 10 
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This method was adapted from Billett et al31.  endo-Anhydride 3 (0.501 g, 
2.81 mmol) and p-methoxyaniline (0.347 g, 2.81 mmol) were dissolved 
separately in dry acetonitrile before the two were combined.  The 
synthesis of imide 10 was then carried out under reflux at 80°C overnight 
using an oil bath, and the reaction was monitored by TLC (25% ethyl 
acetate/diethyl ether) until the product formation seemed to have 
completed.  The solvent was removed in vacuo and the product was 
recrystallised from ethanol to give imide 10 as white fluffy crystals (0.593 g, 
74%), m.p. 158-161°C; Anal. Calc. for C17H17NO3: C, 72.06; H, 6.05; N, 
4.94.  Found: C, 72.30; H, 6.27; N, 4.98%.  IR (KBr in CH3CN): 1777 cm
-1 
(imide C=O), 1709 cm-1 (imide C=O).  1H NMR (400.13 MHz) (CDCl3): δ 
1.44 (m, 2H, H-7a,8a or H7b,8b), 1.63 (m, 2H, H7a,8a or H7b,8b), 2.98 (m, 
2H, H1,4), 3.24 (m (br), 2H, H2,3), 3.81 (m, 3H, OCH3), 6.29 (dd, 2H, 
H5,6), 6.93-6.95 (dd, 2H, H2’,6’), 7.07-7.10 (dd, 2H, H3’,5’). 
   
3.4 Solutions preparation for kinetic studies of ring-opening 
of imide 10 
During the conversion of imide 10 to acid-amide 9 (Figure 2-10), OH- is 
consumed but only at a ratio of one mole per every mole of imide.  
Therefore at the low concentrations of imide (ca. 7x10-5 mol L-1) in the 
reaction solutions monitored for kinetics, this would have a negligible 
effect on the concentration of OH- (0.004-0.020 mol L-1). 
 
The following solutions were prepared:  
 1.00 mol L-1 potassium chloride (KCl) solution 
 Standardised 0.10 mol L-1 potassium hydroxide (KOH) in 0.90 mol 
L-1 KCl solution 9 (overall ionic strength 1.00) 
 0.0035 mol L-1 imide stock solution in THF 
 
The kinetic studies of imide ring opening reaction at hydroxide 
concentration of 0.020 mol L-1 were carried out by adding the imide (50 µL) 
into the KCl solution (2 mL) in a quartz cell cuvette.  This was placed in the 
thermostated cell block of the UVIKON spectrophotometer at 30.0°C and 
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was referenced against an identical solution in a reference cell.  The 
reaction was started by adding KOH solution (0.50 mL, pre-equilibrated at 
30.0°C) to the cell solution in advance to the reference cell.  The 
absorbance values were recorded at 247 nm (λmax of acid-amide
37) at pre-
set time intervals (0.2 minutes) and integration time (0.7 seconds) for 40-
50 cycles until the reaction reached its infinity state.     
 
The experiment was repeated similarly at different hydroxide 
concentrations (0.004-0.020 mol L-1; refer to the following table), while the 
time intervals and λmax were kept constant. 
   
Table 3-1: Preparation of solutions for kinetic runs 
Total Hydroxide 
concentration 
[OH
-
] 
(mol L
-1
) 
1.0 mol L
-1
 
KCl solution 
(mL) 
Imide stock 
solution 
(mL) 
0.10 mol L
-1
 KOH / 
0.90 mol L
-1
 KCl solution 
(mL) 
0.0200 2.00  
0.050  
0.50  
0.0160 2.10  0.40  
0.0120 2.20  0.30  
0.0100 2.25  0.25  
0.0080 2.30  0.20  
0.0060 2.35  0.15  
0.0040 2.40 0.10  
 
3.4.1 Calculation of rate constants for forward and reverse 
reactions (kr and kf) 
For each hydroxide concentration, absorbance recorded at each time 
interval (At) was subtracted from the absorbance at infinity (A∞), and later 
log10(A∞- At) was plotted against time.  The observed rate constant (kobs) 
was determined by multiplying the gradient of the linear graph by -2.303 
(see equation (8) in section 0). 
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Once all the kobs values were determined for every hydroxide 
concentration, they were plotted against [OH-] to obtain a linear graph.  
From this the rate constants for forward and reversed reaction (kf and kf 
respectively) could be determined (see section 2.4.1), where: 
kr = y-intercept; 
kf = gradient. 
 
 
3.5 Kinetic studies of acid-amide 9 conversion using various 
buffer solutions 
In this section all UV/Vis studies were conducted on a Hewlett-Packard 
Agilent 8453 Diode Array spectrophotometer   
 
3.5.1 Introduction 
An alternative of using different concentrations of potassium hydroxide 
solutions is to use a series of buffered solutions which avoids the need to 
keep the reaction conditions to be CO2-free.  However, using buffered 
solutions might give some buffer reactions or catalysis.  For example, for 
carbonate buffer solutions, CO3
2- may act as base in place of OH- to open 
the imide to amide, whereas HCO3
- may act as a general acid to catalyse 
the reaction.  Likewise for the reverse reaction, reformation of imide from 
amide might possibly be acid-catalysed by HCO3
-.  The catalysis problem 
would need to be checked by diluting the buffered solutions at constant pH 
(i.e. constant ratio of CO3
2-/HCO3
-) and ionic strength and using the diluted 
solutions to check for reduced rate. 
 
The various buffer solutions for kinetic runs were prepared at constant 
ionic strength µ = 1.00, where: 
  
For example, for a carbonate buffer solution made up with KHCO3 and 
K2CO3: 
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where the last two terms represent [K+] and [Cl-] from 2.0 mol L-1 KCl 
solution added to bring the nett ionic strength to 1.00.  For other buffer 
solutions, KCl was routinely used to maintain ionic strength at 1.00. 
 
3.5.2 Preparation of buffer solutions 
The following solutions were prepared: 
 0.200 mol L-1 KHCO3 solution 
 0.200 mol L-1 K2CO3 solution 
 0.200 mol L-1 KH2PO4 solution 
 0.200 mol L-1 K2HPO4 solution 
 0.200 mol L-1 H(COO)2KCH2  (KHMal) solution 
 0.200 mol L-1 (COO)2K2CH2  (K2Mal) solution 
 0.200 mol L-1 H2(COO)2CH2  (H2Mal) solution 
 2.0 mol L-1 KCl solution 
 
A series of carbonate, phosphate and malonate buffer solutions (all with a 
concentration of 0.100 mol L-1 and an ionic strength of 1.0) were prepared 
by mixing the above solutions at different ratios: 
  
Table 3-2: Preparation of carbonate buffer solutions (pH range 9-10) 
KHCO3/K2CO3 
buffer ratio 
KHCO3 
solution 
(mL) 
K2CO3 
solution 
(mL) 
KCl solution 
(mL) 
Water 
(mL) 
1:5 1.7 8.3 7.4 2.6 
1:1 5.0 5.0 8.0 2.0 
3:1 7.5 2.5 8.5 1.5 
5:1 8.3 1.7 8.7 1.3 
10:1 9.1 0.9 8.8 1.2 
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Table 3-3: Preparation of phosphate buffer solutions (pH range 5.5-7.5) 
KH2PO4/K2HPO4 
buffer ratio 
KH2PO4  
solution  
(mL) 
K2HPO4 
solution  
(mL) 
KCl 
solution 
(mL) 
Water 
(mL) 
1:9 1.0 9.0 7.2 2.8 
1:3 2.5 7.5 7.5 2.5 
1:1 5.0 5.0 8.0 2.0 
3:1 7.5 2.5 8.5 1.5 
4:1 8.0 2.0 8.6 1.4 
5:1 8.3 1.7 8.7 1.3 
7:1 8.8 1.2 8.8 1.2 
9:1 9 1 8.8 1.2 
 
Table 3-4: Preparation of malonate buffer solutions (second ionisation) (pH range 
4.5-8.5) 
KHMal/K2Mal 
buffer ratio 
KHMal 
solution  
(mL) 
K2Mal 
solution  
(mL) 
KCl solution 
(mL) 
Water 
(mL) 
1:9 1.0 9.0 7.2 2.8 
1:3 2.5 7.5 7.5 2.5 
1:1 5.0 5.0 8.0 2.0 
3:1 7.5 2.5 8.5 1.5 
5:1 8.3 1.7 8.7 1.3 
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Table 3-5: Preparation of malonate buffer solutions (first ionisation) (pH range 2-4) 
H2Mal/KHMal 
buffer ratio 
H2Mal 
solution 
(mL) 
KHMal 
solution 
(mL) 
KCl solution 
(mL) 
Water 
(mL) 
1:9 1.00 9.00 9.1 0.9 
1:7 1.25 8.75 9.1 0.9 
1:5 1.67 8.33 9.2 0.8 
1:3 2.50 7.50 9.3 0.7 
1:1 5.00 5.00 9.5 0.5 
3:1 7.50 2.50 9.8 0.2 
 
 
3.5.3 Kinetic studies to establish pH-rate profile of acid-amide 9 
Imide 10 (5 mg) was dissolved in THF (1 mL) and the resulting solution 
was dripped slowly into a KOH solution (5 mL, 0.1 mol L-1).  The resulting 
ionised acid-amide 9 formed from 10 was then used for the kinetic 
analysis which was conducted on a Hewlett Packard Agilent 8453 UV/Vis 
spectrophotometer. 
 
The reaction was started by adding the acid-amide (50 µL) to the 1:5 
carbonate buffer solution (2.5 mL) which had been left in the cell block to 
temperature-equilibrate for 15 minutes, and the absorbance values were 
recorded at pre-set time intervals (14 seconds) and integration time (0.5 
seconds).  The run time of the instrument was pre-set at 40,000 seconds 
so as to incorporate at least 10 half-lives of the hydrolysis reaction. 
   
The pH of the cell solution was measured after the reaction was 
completed.  The experiment was repeated using the other carbonate 
buffer solutions, as well as phosphate and malonate buffer solutions at 
different ratios, while the time interval and wavelength were kept constant.   
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The analysis was carried out using the Agilent Chemstation software.  The 
first order kinetics method option in this software plots an exponential 
graph according to the following equation: 
 
From this equation, the kobs values and their standard deviations were 
calculated directly with a best fit curve fitted to data plotted as absorbance 
versus time. 
 
The absorbance data at 247 nm (λmax of acid-amide) were routinely used 
to calculate the rate constants.  An example of a typical spectrum obtained 
by this software is shown in Appendix E. 
 
Even though the reaction was left to run for 40,000 seconds, the infinity 
data were not used because of over-emphasis on the small absorbance 
values at the late stages of the reaction in the curve fitting, but the 
analyses were conducted so that stable infinity values could be seen to 
ensure there was no any problem of drift calculated by the software. 
 
A graph of kobs against pH was then plotted to establish the pH-rate profile 
of acid-amide 9 (refer to Figure 2-14). 
 
To establish that the neutral acid-amide gave only hydrolysis products not 
imide, a one-off reaction in malonate buffer at pH 3.9 was carried out and 
subsequently, the pH was raised to 11.1 with added K3PO4.  The absence 
of any detectable absorbance change at 247 nm showed the absence of 
any imide in product solution. 
 
3.5.4 Buffer dilutions 
Buffer solutions were normally prepared at the concentration of 0.100 mol 
L-1.  However, at a high concentration like this exists a potential buffer 
catalytic problem on the rates of the hydrolysis reaction.   
 
56 
 
Buffer catalysis is known to occur for a few aryl amines with neighbouring 
carboxylate groups as reported by Kluger and Lam38.  Therefore, a study 
was conducted to check for any existence of buffer catalytic effect on the 
reactions. 
The buffer dilution analysis was carried out by diluting, two-fold and four-
fold, the 1:1 buffer solution of the carbonate, phosphate and malonate 
buffer solutions.  Subsequently, the solutions were analysed by running 
the amide hydrolysis reactions in them while keeping all the other 
parameters the same.  If no buffer catalysis was occurring, there would be 
no change in solution pH and rate of hydrolysis reaction even though the 
concentration of buffer solution was being halved or quartered.  On the 
other hand, if buffer catalysis was occurring, the reaction rate would be 
less than that determined from the reaction run in buffer solution of 0.100 
mol L-1.   
 
It was found that all the buffer solutions do not show any significant buffer 
catalytic reactions as the resulting reaction rates were consistent, to a 
measurable extent at least, with those determined for the solutions with full 
buffer concentration.   
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4 Summary and Conclusions 
The initial goal of the current study was to synthesise an  endo-acid-amide 
in its un-ionised form, purify it, and to obtain a full pH-rate profile for its 
cyclisation to release amine and anhydride.   
 
This was initially attempted by using N-methylaniline but this was not 
successful probably due to the nature of the sterically crowded secondary 
amine molecule. 
   
The synthetic plan was diverted to replace N-methylaniline with p-
methoxyaniline, a less sterically crowded primary amine molecule.  Again, 
this did not succeed as a pure acid-amide product could not be obtained.  
As a result, an endo-imide 10 was prepared, purified, and the imide was 
ring was opened in KOH solution to give a solution of pure acid-amide 
carboxylate 9 (Figure 4-1), which could then be used for kinetic analyses. 
N
O
O
OCH3
H
N
O
O
OCH3
O
-
10
9
+ OH
 -
 
Figure 4-1: Conversion of imide to acid-amide 
 
The pH-rate profile of acid-amide 9 was established over the pH range of 
3-10.  At 30°C, the limiting rate constant for hydrolysis of acid-amide 9 in 
its fully neutral form was calculated to be 0.44±0.03 min-1, whereas the 
dissociation constant pKa was determined to be 5.1±0.4.  The rate 
constant for formation of imide 10 from fully ionised 9, which was 
represented by higher pH plateau rate (pH above 8), klow, was calculated 
to be 0.067 min-1.  The neutral form of 9 was shown to undergo hydrolysis 
only as a product solution showed no ring opening reaction of imide when 
the pH was raised to 11. 
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O
O
N
OH
CH3
NH
H
H
  
Figure 4-2: Glüsenkamp's acid-amide 
 
Although Glüsenkamp’s acid-amide (Figure 4-2) showed a considerably 
higher hydrolysis rate constant of 6.93 min-1 (determined at 37°C and 0.15 
molL-1 salt concentration)22, the rate of hydrolysis of acid-amide 9 in the 
current study is comparable to that of Kluger’s acid-amide (Figure 4-3) 
which has a hydrolysis rate constant of 0.87 min-1 (determined at 50°C)34.   
 
O
O
H
N
OH
OCH3     
Figure 4-3: Kluger's acid-amide 
 
In relation to prodrug application, the kobs value was determined to be 0.11 
min-1 at pH 6.02 and 0.07 min-1 at pH 7.06.  The rate difference was not as 
favourably large as hoped because the pKa was lower than anticipated 
from the value for similar amides in the Glüsenkamp series.  Although it 
could be concluded that the results have attained the initial aim of 
releasing the amine at higher rate at pH 6 than in pH 7, the difference is 
such that it is questionable whether there would be a potential for 
attaching a cytotoxic amine in place of p-methoxyaniline and testing the 
anticancer activity on cancer cells. 
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At higher pH where there is no neutral acid-amide, the equilibrium reaction 
between imide and the acid-amide carboxylate was also studied.  The 
second order rate constant for the formation from imide and OH- of amide 
carboxylate (kf) was determined to be 74±16 L mol
-1 min-1, the reverse rate 
constant for imide formation 0.067 min-1 and thereby the equilibrium 
constant K as 1100 L mol-1. 
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Appendix A – Glycolytic pathway 
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Figure A-1: Glycolytic pathway 
  
    
  
6
6
 
Appendix B – 1H NMR spectrum of imide 10 
 
Figure B-1: Proton NMR of imide 10 
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Appendix C – Graph for determining errors 
 
Figure C-1: Graph for determining error of kobs 
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Figure C-2: Graph for determining errors of kr and kf 
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Appendix D – Error estimation of klim and pKa 
 
Figure D-1: Graph for determining errors of klim and pKa 
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The values for slope and y-intercept were calculated to be 
2.0E+05±1.1E+05 and 2.69±0.16.  These were calculated from the 
maximum and minimum slopes and y-intercepts of the following graph. 
 
Error estimation of pKa 
 
From equation (7): 
  
 
Therefore,  
  
 
  
 
  
 
  
 
  
 
Therefore, pKa = 5.13±0.35 
 
Error estimation of klim 
 
From equation (7): 
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Therefore, klim = 0.044±0.032 
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Appendix E – UV/Vis spectra obtained from Agilent 
Chemstation Software 
 
Figure E-1: Example of the kinetic analysis data 
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Figure E-2: Typical repetitive scanning spectra for hydrolysis of acid-amide 
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Appendix F – Theory of first order rate constants32 
The rate of a first-order reaction is proportional to the concentration of a 
single species: 
A→P      ----- (1)   
Other reactants can be present but will be zero-order.  A first order 
reaction is described by a rate constant, k, with the dimensions of 
reciprocal time, such as sec-1 or min-1: 
 
   ----- (2)  
 
Equation 2 for a first-order reaction may be integrated from t0 to the time of 
an experimental measurement according to the following equations, in 
which A0 is the concentration of A at zero time. 
 
     
 
     
 
       
 
     
 
    
 
   ----- (3) 
The variables in these equations are [A] and t, so that the concentration of 
A decreases exponentially and a plot of log10 [A] against t is linear with a 
slope of –k/2.303.  The half-life, t1/2, of the reaction is the time at which the 
concentration of A has decreased to half of its initial value, 0.5 A0: 
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   ----- (4) 
 
When working with a UV/Vis spectrophotometer, absorbance, A increases 
with time if the product absorbs more than the reactant at the monitoring 
wavelength.  In this case, A∞-A0 is thus directly proportional to [A0], and 
A∞-At is directly proportional to [At].  Therefore, by plotting log10[A∞-At] 
against t the rate constant k can be calculated from the slope of the 
straight line: 
 
    ----- (5) 
 
And therefore t1/2 can be calculated from equation 4: 
 
     ----- (5) 
 
In practice, if absorbance increases during an experiment, log10(A∞-At) can 
be plotted against time.  If absorbance is decreasing, then log10(At-A∞) is 
plotted against t.   
 
An alternative method to determine the reaction rate constant for a first-
order reaction is the Guggenheim method39, 40.  This method is used when 
the final absorbance reading A∞ is unreliable or is taking too long to 
achieve. 
According to Guggenheim, if times t1, t2, t3, etc., and t1 + Δt, t2 + Δt, t3 + Δt, 
etc., are selected (where Δt is a constant time increment), then the graph 
of log10[At-(At+Δt)] against t or [log10(At+Δt)-At] against t) can be plotted to 
obtain a linear plot, the slope of which is used to determine the rate 
constant k as in equation 5.   
To be able to use the Guggenheim method, it must be certain that the 
reaction is a simple first-order reaction, since other more complex 
reactions (e.g. reversible and concurrent first-order reactions) can give 
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apparent linearity and false rate constants by this method.  On the other 
hand, the time interval Δt should best be two or three times as great as the 
half life period of the reaction, for accuracy purposes. 
 
 
